NCT03561766 Birth Cohort Study of China Medical University
| NCT ID | NCT03561766 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shengjing Hospital |
| Condition | Twin; Complicating Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-06-15 |
| Primary Completion | 2020-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-06-15 with a primary completion date of 2020-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.
Eligibility Criteria
Inclusion Criteria: 1. Pregnant women, \<13 gestational weeks 2. Permanent residents or families intended to remain in Shenyang and surrounding areas 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital. Exclusion Criteria: 1. Pregnant women who refuse to take part in the study 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.
Contact & Investigator
Caixia Liu
PRINCIPAL INVESTIGATOR
Shengjing Hospital
Frequently Asked Questions
Who can join the NCT03561766 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Twin; Complicating Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03561766 currently recruiting?
Yes, NCT03561766 is actively recruiting participants. Contact the research team at liucx1716@163.com for enrollment information.
Where is the NCT03561766 trial being conducted?
This trial is being conducted at Shenyang, China.
Who is sponsoring the NCT03561766 clinical trial?
NCT03561766 is sponsored by Shengjing Hospital. The principal investigator is Caixia Liu at Shengjing Hospital. The trial plans to enroll 1,000 participants.